We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention. 

Carla Chibwesha, MD, MSc, will collaborate with investigators in a multi-institutional project to develop trials to be conducted at clinical sites in Kenya, Uganda and Botswana.

A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.

Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.

UNC Lineberger’s Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.